These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19717280)

  • 21. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
    Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells.
    Warren A; Le Couteur DG; Fraser R; Bowen DG; McCaughan GW; Bertolino P
    Hepatology; 2006 Nov; 44(5):1182-90. PubMed ID: 17058232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of PD-1 on CD4⁺CD25⁺ T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis.
    La X; Zhang F; Li Y; Li J; Guo Y; Zhao H; Pang N; Ma X; Wen H; Fan H; Ding J
    Int Immunopharmacol; 2015 Jun; 26(2):357-66. PubMed ID: 25907244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
    Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
    J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance.
    Diehl L; Schurich A; Grochtmann R; Hegenbarth S; Chen L; Knolle PA
    Hepatology; 2008 Jan; 47(1):296-305. PubMed ID: 17975811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
    Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
    Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells.
    Carambia A; Frenzel C; Bruns OT; Schwinge D; Reimer R; Hohenberg H; Huber S; Tiegs G; Schramm C; Lohse AW; Herkel J
    J Hepatol; 2013 Jan; 58(1):112-8. PubMed ID: 22989568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms balancing tolerance and immunity in the liver.
    Böttcher JP; Knolle PA; Stabenow D
    Dig Dis; 2011; 29(4):384-90. PubMed ID: 21894009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aetiopathogenesis of autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3- regulatory T cells suppressing autoimmune hepatitis.
    Kruse N; Neumann K; Schrage A; Derkow K; Schott E; Erben U; Kühl A; Loddenkemper C; Zeitz M; Hamann A; Klugewitz K
    Hepatology; 2009 Dec; 50(6):1904-13. PubMed ID: 19787806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles.
    Ilyinskii PO; Roy CJ; LePrevost J; Rizzo GL; Kishimoto TK
    Front Immunol; 2021; 12():637469. PubMed ID: 34113339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.
    Carambia A; Freund B; Schwinge D; Heine M; Laschtowitz A; Huber S; Wraith DC; Korn T; Schramm C; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2014 Sep; 61(3):594-9. PubMed ID: 24798620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.
    Fisicaro P; Barili V; Rossi M; Montali I; Vecchi A; Acerbi G; Laccabue D; Zecca A; Penna A; Missale G; Ferrari C; Boni C
    Front Immunol; 2020; 11():849. PubMed ID: 32477347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.